Skip to main content

Day: November 26, 2019

Teck Media and Investor Webcast Advisory

VANCOUVER, British Columbia, Nov. 26, 2019 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) President and Chief Executive Officer, Don Lindsay will be presenting at the Citi Basic Materials Conference on Wednesday, December 4, 2019 at 10:15 a.m. Eastern/7:15 a.m. Pacific time. The investor presentation will include information on company strategy, financial performance, and outlook for the company’s business units.The presentation will be webcast through the following link at:http://www.veracast.com/webcasts/citigroup/basicmaterials2019/01204309342.cfm.Alternatively, the webcast with supporting slides will be available on Teck’s website at: www.teck.com.About TeckTeck is a diversified resource company committed to responsible mining and mineral development with major business units focused...

Continue reading

Aqua Bio Technology ASA – further distribution of the skin care series Cuvget in EMEA

Reference is made to the announcement of 12 January, 2017 regarding Aqua Bio Technology’s (ABT) distribution agreement with Scandiderma AS (Scandiderma) for the distribution of the skin care series Cuvget (the Distribution Agreement).As per the Distribution Agreement, ABT has been holding exclusive distribution rights for Cuvget in EMEA (Europe, the Middle East and Africa).The market response to the Cuvget products in their present form, as well as the sales of the skin care series, have failed to mirror ABT’s expectations. Therefore, ABT has decided not to meet its commitments related to the minimum order set out in the Distribution Agreement and its appendices.ABT and Scandiderma have been engaged in negotiations over a new, exclusive distribution agreement and a reformulation of the skin care series. However, the parties have not succeeded...

Continue reading

Aqua Bio Technology ASA – videre distribusjon av hudpleieserien Cuvget i EMEA

Det vises til børsmelding 12. januar 2017 vedrørende Aqua Bio Technology ASAs (ABT) inngåelse av en distribusjonsavtale med Scandiderma AS (Scandiderma) for distribusjon av hudpleieserien Cuvget (Distribusjonsavtalen).I henhold til Distribusjonsavtalen er ABT gitt en eksklusiv rett til distribusjon av Cuvget i EMEA (Europa, Midt-Østen og Afrika).Tilbakemeldingene på Cuvget produktene i sin nåværende form og salget av hudpleieserien Cuvget har ikke gjenspeilet de forventningene ABT hadde til hudpleieserien, og ABT har derfor valgt å ikke møte forpliktelsene knyttet til minimumsordre som følger av Distribusjonsavtalen og dens vedlegg. ABT og Scandiderma AS har forhandlet om en ny eksklusiv distribusjonsavtale og en reformulering av hudpleieserien, men har ikke lykkes å komme til enighet om vilkårene for et videre eksklusivt samarbeid. ABT...

Continue reading

Assertio Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference

LAKE FOREST, Ill., Nov. 26, 2019 (GLOBE NEWSWIRE) — Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the 31st Annual Piper Jaffray Healthcare Conference in a session scheduled for 9:30 a.m. ET, Thursday, December 5, 2019 in New York, NY.This presentation will be webcast and can be accessed via the Investor Relations page of the Assertio website at http://investor.assertiotx.com. Please access the website 15 minutes prior to the start of the call to download and install any necessary audio software. A recording of the webcast will be archived.About Assertio Therapeutics, Inc.Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines. Assertio currently markets...

Continue reading

DIAGNOS Announces Short Term Financing

BROSSARD, Quebec, Nov. 26, 2019 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB:DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces a financing of $400,000 in the form of one short term debt agreement.DIAGNOS and one arm’s length person (the “Lender”) have entered into one unsecured and non-convertible loan agreement (the “Loan”) for an amount of $400,000. The Loan bears no interest and is repayable by the Corporation at the earliest of (i) the closing date of a future round of financing of at least $3,000,000, or (ii) May 26th, 2020. As a bonus to the Loan, the Corporation is granting the Lender 3,076,922 non-transferable share purchase warrants (each a “Warrant”) enabling its holder to purchase...

Continue reading

NATIXIS STATEMENT

                                                                                                                                           Paris, November 26th, 2019Natixis statementFollowing press articles related to the suspension of a trader at Natixis’ Americas platform, Natixis would like to make it clear that it constantly monitors and reviews its employees’ performance through well-established internal procedures that are applicable to all employees.Regarding the case mentioned by a Bloomberg article published on November 26th, it is a purely internal procedure that is by no means related to a P&L loss and has no impact whatsoever on Natixis’ clients or businesses.About NatixisNatixis is a French multinational financial services firm specialized in asset & wealth management, corporate & investment banking, insurance...

Continue reading

Déclaration de Natixis

                                                                                                        Paris, le 26 novembre 2019Déclaration de NatixisÀ la suite d’articles de presse évoquant la suspension d’un trader de la plateforme Amériques de Natixis, Natixis tient à préciser qu’elle suit et revoit constamment les performances de ses collaborateurs grâce à des procédures internes solides, applicables à l’ensemble des salariés.Concernant le cas individuel évoqué par un article de Bloomberg en date du 26 novembre, il s’agit d’une procédure purement interne qui n’est en aucun cas liée à une perte en résultat et est sans conséquence aucune sur les clients ou les activités de Natixis.À propos de NatixisNatixis est un établissement financier français de dimension internationale spécialisé dans la gestion d’actifs et de fortune, la banque...

Continue reading

Melco Resorts Finance Announces Pricing of Senior Notes Offering

MACAU, Nov. 27, 2019 (GLOBE NEWSWIRE) — Melco Resorts Finance Limited (“Melco Resorts Finance”) announces that it has priced its international offering of senior notes (the “New Notes”). Melco Resorts Finance is a wholly-owned subsidiary of Melco Resorts & Entertainment Limited (“Melco”). The offering consists of US$900 million aggregate principal amount of 5.375% senior notes due 2029. The New Notes were priced at 100%. Melco Resorts Finance intends to use the net proceeds from the offering to make a full repayment of the principal amount outstanding under the revolving credit facility and a partial prepayment of the principal amount outstanding under the term loan facility under the amended and restated credit facilities entered into by Melco Resorts (Macau) Limited, a subsidiary of Melco Resorts Finance, in 2015.The New Notes...

Continue reading

The 4Less Corp. Increases Direct Sales On Website By 61% in Q2 2019 Compared to 2018

LAS VEGAS, Nov. 26, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — The 4Less Group, Inc. (OTC: FLES) is pleased to announce that its wholly owned subsidiary Auto Parts 4Less, Inc. (“4Less”, or the “Company”) the owner of Liftkits4less.com (www.liftkits4less.com) (“Liftkits”) has seen a 61% increase in revenue on its liftkits4less.com website for the second quarter of 2019 as compared to the same quarter last year. During Q2 2018, direct sales on the Company’s proprietary website represented 26% of overall sales for that quarter, and during Q2 2019 direct sales represented 42% of overall sales for an increase of 61% between both quarters.“We are moving towards the 50% mark where half of our overall sales would come directly from our proprietary website,” said Christopher Davenport, President and CEO of The 4 Less Corp. “Our strategy...

Continue reading

Generex Biotechnology Issues Shareholder Alert

MIRAMAR, Fla., Nov. 26, 2019 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (OTCQB: GNBT) has issued a shareholder alert regarding recent trading activity that has adversely affected the company and its shareholders. It has been brought to our intention that Creek Mountain Fund, from which Generex acquired 20% of Olaregen Therapeutix shares in exchange for GNBT shares, has been illegally selling its 4 million share position without notifying the Securities & Exchange Commission nor Generex shareholders of their plans to sell the GNBT stock through filing a Form 13g.Joe Moscato, President & CEO of Generex stated, “It is unfortunate that Creek Mountain has decided to hurt Generex and our shareholders with their actions. Generex is working with our legal team to review compliance with our asset purchase agreements (APAs)...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.